Menu

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Publication

Date

Link to Article

Jerusalem Post

February 21, 2021

Original Article

Title

Paste body copy

Related Posts

Back To Top
© Patensee 2024
Powered by: SPInc

PatenSee is an emerging, clinical-stage, startup company with a novel, contactless imaging device for the early detection of vascular access complications in hemodialysis patients. The technology uses a unique data stream to mimic a best practice, physical examination. PatenSee recently signed a clinical collaboration agreement with Fresenius Medical Care, following the completion of a POC clinical trial with very promising results.


PatenSee is a portfolio company of MEDX Xelerator, a medical device incubator backed by Boston Scientific, Sheba Medical Center, MEDX Ventures Group, Consensus Business Group (CBG), West Pharmaceuticals and The Portland Trust.